Patents by Inventor James P. Quigley

James P. Quigley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for diagnosing cancer and decreasing metastasis by cancer cells
    Publication number: 20130142798
    Abstract: The invention provides a protein that is a tumor marker protein. This protein can be used to prepare antibodies that bind to the tumor marker protein. These antibodies can be used to reduce, or eliminate metastasis by cancer cells that produce the tumor marker protein. In addition, the invention provides methods that can be used to diagnose cancer, and metastasis by cancer cells.
    Type: Application
    Filed: October 4, 2012
    Publication date: June 6, 2013
    Inventors: James P. Quigley, John D. Hooper, Jacqueline E. Testa
  • Methods for diagnosing cancer and decreasing metastasis by cancer cells
    Publication number: 20120039891
    Abstract: The invention provides a protein that is a tumor marker protein. This protein can be used to prepare antibodies that bind to the tumor marker protein. These antibodies can be used to reduce, or eliminate metastasis by cancer cells that produce the tumor marker protein. In addition, the invention provides methods that can be used to diagnose cancer, and metastasis by cancer cells.
    Type: Application
    Filed: September 14, 2011
    Publication date: February 16, 2012
    Applicant: The Scripps Research Institute
    Inventors: James P. Quigley, John D. Hooper, Jacqueline E. Testa
  • Methods for diagnosing cancer and decreasing metastasis by cancer cells
    Publication number: 20100158917
    Abstract: The invention provides a protein that is a tumor marker protein. This protein can be used to prepare antibodies that bind to the tumor marker protein. These antibodies can be used to reduce, or eliminate metastasis by cancer cells that produce the tumor marker protein. In addition, the invention provides methods that can be used to diagnose cancer, and metastasis by cancer cells.
    Type: Application
    Filed: September 10, 2009
    Publication date: June 24, 2010
    Applicant: The Scripps Research Institute
    Inventors: James P. Quigley, John D. Hooper, Jacqueline E. Testa
  • Methods for diagnosing cancer and decreasing metastasis by cancer cells
    Patent number: 7589173
    Abstract: The invention provides a protein that is a tumor marker protein. This protein can be used to prepare antibodies that bind to the tumor marker protein. These antibodies can be used to reduce, or eliminate metastasis by cancer cells that produce the tumor marker protein. In addition, the invention provides methods that can be used to diagnose cancer, and metastasis by cancer cells.
    Type: Grant
    Filed: February 18, 2004
    Date of Patent: September 15, 2009
    Assignee: The Scripps Research Institute
    Inventors: James P. Quigley, John D. Hooper, Jacqueline E. Testa
  • Methods for diagnosing cancer and decreasing metastasis by cancer cells
    Publication number: 20040247601
    Abstract: The invention provides a protein that is a tumor marker protein. This protein can be used to prepare antibodies that bind to the tumor marker protein. These antibodies can be used to reduce, or eliminate metastasis by cancer cells that produce the tumor marker protein. In addition, the invention provides methods that can be used to diagnose cancer, and metastasis by cancer cells.
    Type: Application
    Filed: February 18, 2004
    Publication date: December 9, 2004
    Inventors: James P. Quigley, John D. Hooper, Jacqueline E. Testa
  • Monoclonal antibodies that recognize antigens associated with tumor metastasis
    Patent number: 6498014
    Abstract: This invention provides tumor metastasis-inhibiting monoclonal antibodies, mAb 41-2, mAb 50-6 and mAb 1A-5. The antigen recognized by mAb 50-6 and mAb 1A-5 has been identified as the PETA-3 antigen. The antigen recognized by mAb 41-2 has been identified as a novel tumor metastasis-associated antigen. Compositions and methods are provided that are useful for treating and diagnosing metastatic tumors.
    Type: Grant
    Filed: February 8, 2000
    Date of Patent: December 24, 2002
    Assignee: The Research Foundation of State University of NY
    Inventors: Jacqueline E. Testa, James P. Quigley, Marco Seandel
  • Monoclonal antibodies that recognize antigens associated with tumor metastasis
    Patent number: 6245898
    Abstract: This invention provides tumor metastasis-inhibiting monoclonal antibodies, mAb 41-2, mAb 50-6 and mAb 1A-5. The antigen recognized by mAb 50-6 and mAb 1A-5 has been identified as the PETA-3 antigen. The antigen recognized by mAb 41-2 has been identified as a novel tumor metastasis-associated antigen. Compositions and methods are provided that are useful for treating and diagnosing metastatic tumors.
    Type: Grant
    Filed: June 15, 1999
    Date of Patent: June 12, 2001
    Assignee: The Research Foundation of State University of New York
    Inventors: Jacqueline E. Testa, James P. Quigley, Marco Seandel